Cargando…

Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis

BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Whaley, Colin, Bancsi, Ashley, Ho, Joanne Man-Wai, Burns, Catherine M., Grindrod, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836591/
https://www.ncbi.nlm.nih.gov/pubmed/33499869
http://dx.doi.org/10.1186/s12913-021-06103-1
_version_ 1783642782307450880
author Whaley, Colin
Bancsi, Ashley
Ho, Joanne Man-Wai
Burns, Catherine M.
Grindrod, Kelly
author_facet Whaley, Colin
Bancsi, Ashley
Ho, Joanne Man-Wai
Burns, Catherine M.
Grindrod, Kelly
author_sort Whaley, Colin
collection PubMed
description BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patient adherence, however RFU is rarely added on prescriptions by prescribers or on medication labels for patients to reference. METHODS: Qualitative interviews were conducted with 20 prescribers in Southern Ontario, Canada, to learn prescribers’ current attitudes on the addition of RFU on prescriptions and medication labels. A trained interviewer used a semi-structured interview guide for each interview. The interviews explored how the sharing of RFU information would impact prescribers’ workflows and practices. Interviews were recorded, transcribed and thematically coded. RESULTS: The analysis yielded four main themes: Current Practice, Future Practice, Changing Culture, and Collaboration. Most of the prescribers interviewed do not currently add RFU to prescriptions. Prescribers were open to sharing RFU with colleagues via a regional database but wanted the ability to provide context for the prescribed medication within the system. Many prescribers were wary of the impact of adding RFU on their workflow but felt it could save time by avoiding clarifying questions from pharmacists. Increased interprofessional collaboration, increased patient understanding of prescribed medications, avoiding guesswork when determining indications and decreased misinterpretation regarding RFU were cited by most prescribers as benefits to including RFU information. CONCLUSIONS: Prescribers were generally open to sharing RFU and clearly identified the benefits to pharmacists and patients if added. Critically, they also identified benefits to their own practices. These results can be used to guide the implementation of future initiatives to promote the sharing of RFU in healthcare teams. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06103-1.
format Online
Article
Text
id pubmed-7836591
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78365912021-01-27 Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis Whaley, Colin Bancsi, Ashley Ho, Joanne Man-Wai Burns, Catherine M. Grindrod, Kelly BMC Health Serv Res Research Article BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patient adherence, however RFU is rarely added on prescriptions by prescribers or on medication labels for patients to reference. METHODS: Qualitative interviews were conducted with 20 prescribers in Southern Ontario, Canada, to learn prescribers’ current attitudes on the addition of RFU on prescriptions and medication labels. A trained interviewer used a semi-structured interview guide for each interview. The interviews explored how the sharing of RFU information would impact prescribers’ workflows and practices. Interviews were recorded, transcribed and thematically coded. RESULTS: The analysis yielded four main themes: Current Practice, Future Practice, Changing Culture, and Collaboration. Most of the prescribers interviewed do not currently add RFU to prescriptions. Prescribers were open to sharing RFU with colleagues via a regional database but wanted the ability to provide context for the prescribed medication within the system. Many prescribers were wary of the impact of adding RFU on their workflow but felt it could save time by avoiding clarifying questions from pharmacists. Increased interprofessional collaboration, increased patient understanding of prescribed medications, avoiding guesswork when determining indications and decreased misinterpretation regarding RFU were cited by most prescribers as benefits to including RFU information. CONCLUSIONS: Prescribers were generally open to sharing RFU and clearly identified the benefits to pharmacists and patients if added. Critically, they also identified benefits to their own practices. These results can be used to guide the implementation of future initiatives to promote the sharing of RFU in healthcare teams. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06103-1. BioMed Central 2021-01-26 /pmc/articles/PMC7836591/ /pubmed/33499869 http://dx.doi.org/10.1186/s12913-021-06103-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Whaley, Colin
Bancsi, Ashley
Ho, Joanne Man-Wai
Burns, Catherine M.
Grindrod, Kelly
Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title_full Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title_fullStr Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title_full_unstemmed Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title_short Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
title_sort prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836591/
https://www.ncbi.nlm.nih.gov/pubmed/33499869
http://dx.doi.org/10.1186/s12913-021-06103-1
work_keys_str_mv AT whaleycolin prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis
AT bancsiashley prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis
AT hojoannemanwai prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis
AT burnscatherinem prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis
AT grindrodkelly prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis